Hong Kong Pharmaceuticals & Biotech Most Popular Stocks

Hansoh Pharmaceutical Group

Market Cap: HK$209.6b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

WuXi Biologics (Cayman)

Market Cap: HK$168.5b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

Innovent Biologics

Market Cap: HK$153.7b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

CSPC Pharmaceutical Group

Market Cap: HK$115.0b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Sino Biopharmaceutical

Market Cap: HK$114.2b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Akeso

Market Cap: HK$96.0b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$94.8b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

WuXi XDC Cayman

Market Cap: HK$81.2b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Shanghai Bao Pharmaceuticals

Market Cap: HK$65.2b

Operates as a clinical-stage biotechnology company.

3SBio

Market Cap: HK$55.7b

An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.

RemeGen

Market Cap: HK$55.5b

A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.

XtalPi Holdings

Market Cap: HK$45.9b

An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.

Shanghai Henlius Biotech

Market Cap: HK$38.0b

Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.

InSilico Medicine Cayman TopCo

Market Cap: HK$37.4b

Operates as an artificial intelligence (AI)-based biotech company that helps to develop and manufacture novel drugs in Hong Kong, the United States, the United Kingdom, Mainland China, and internationally.

China Medical System Holdings

Market Cap: HK$36.2b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Shanghai Junshi Biosciences

Market Cap: HK$35.2b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.

Simcere Pharmaceutical Group

Market Cap: HK$33.6b

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.

Xuanzhu Biopharmaceutical

Market Cap: HK$32.7b

Engages in the development, industrialization, and commercialization of small-molecule chemical drugs and macromolecular biopharmaceuticals in China.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$32.7b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Duality Biotherapeutics

Market Cap: HK$30.6b

A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.

China Resources Pharmaceutical Group

Market Cap: HK$29.2b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

TransThera Sciences (Nanjing)

Market Cap: HK$27.6b

TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases.

Grand Pharmaceutical Group

Market Cap: HK$26.8b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Genscript Biotech

Market Cap: HK$26.7b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

Sunshine Lake Pharma

Market Cap: HK$24.9b

Engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.

InnoCare Pharma

Market Cap: HK$24.7b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

United Laboratories International Holdings

Market Cap: HK$24.0b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Ab&B Bio-Tech JS

Market Cap: HK$20.7b

Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases.

Ascentage Pharma Group International

Market Cap: HK$18.0b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

PegBio

Market Cap: HK$17.9b

A biopharmaceutical company, focuses on the research and development of medicines for chronic diseases in China.

Ascletis Pharma

Market Cap: HK$17.2b

A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.

Consun Pharmaceutical Group

Market Cap: HK$15.5b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

Keymed Biosciences

Market Cap: HK$15.4b

A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.

CF PharmTech

Market Cap: HK$15.2b

Engages in research and development, production, and sale of respiratory drugs in the field of respiratory diseases in China.

Sihuan Pharmaceutical Holdings Group

Market Cap: HK$14.5b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China and the United States.

Everest Medicines

Market Cap: HK$13.9b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.